Pain Medicine, Interventional Pain Medicine · Columbus, GA
NPI
1972720928
Since 2007
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7351 Old Moon Rd
Columbus, GA, 31909
Phone (706) 653-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$292K
4,006 services
Medicare patients, 2024
597
Average age 67
Drug cost, 2024
$583K
9,063 prescriptions
Company payments, 2025
$2,993
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Takia M Oglesby was code 99214 (office e&m - established), 677 times for 258 patients. In total Takia M Oglesby billed 4,006 services in 55 codes, and Medicare paid $292K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 677 | 258 | $86.99 | $59K |
| 99213 Office E&M - Established | Office | 663 | 400 | $61.89 | $41K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 553 | 42 | $0.08 | $46.75 |
| 80307 Drug Tests | Office | 480 | 291 | $60.55 | $29K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 396 | 80 | $46.80 | $19K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 247 | 177 | $111.71 | $28K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 160 | 113 | $153.46 | $25K |
| 99212 Office E&M - Established | Office | 40 | 24 | $38.59 | $1,544 |
| 99204 Office E&M - New | Office | 34 | 34 | $116.74 | $3,969 |
| 64494 Nerve Block Injection - Back | Office | 32 | 23 | $92.22 | $2,951 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 32 | 28 | $242.26 | $7,752 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 32 | 28 | $445.05 | $14K |
| 64493 Nerve Block Injection - Back | Office | 32 | 23 | $170.36 | $5,451 |
| 27096 Joint Injection | Office | 30 | 25 | $154.69 | $4,641 |
| 62323 Nerve Block Injection - Back | Office | 25 | 22 | $177.10 | $4,427 |
By year: 2022 $280K for 3,609 services; 2023 $253K for 2,926 services; 2024 $292K for 4,006 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 480 | 291 | $60.55 | $29K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 247 | 177 | $111.71 | $28K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 160 | 113 | $153.46 | $25K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 21 | 21 | $194.77 | $4,090 |
Medicare prescription drug claims, 2024
In 2024, the drug Takia M Oglesby prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 1,654 prescriptions and refills. In total Takia M Oglesby wrote 9,063 Medicare prescriptions that cost $583K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,654 | 1,654 | 531 | $84K |
| Tizanidine Hcl Generic | 1,200 | 1,233 | 346 | $5,582 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,099 | 1,099 | 434 | $27K |
| Celecoxib Generic | 921 | 949 | 262 | $12K |
| Pregabalin Generic | 812 | 844 | 272 | $19K |
| Baclofen Generic | 617 | 656 | 172 | $5,947 |
| Oxycodone Hcl Generic | 460 | 460 | 173 | $7,801 |
| Gabapentin Generic | 280 | 287 | 107 | $3,272 |
| Xtampza Er Oxycodone Myristate | 249 | 250 | 60 | $114K |
| Cyclobenzaprine Hcl Generic | 222 | 238 | 61 | $1,610 |
| Morphine Sulfate Er Morphine Sulfate | 221 | 221 | 61 | $5,254 |
| Fentanyl Generic | 189 | 189 | 42 | $16K |
| Duloxetine Hcl Generic | 100 | 121 | 33 | $1,417 |
| Diclofenac Sodium Generic | 69 | 81 | 28 | $21K |
| Tramadol Hcl Generic | 64 | 64 | 26 | $460 |
Brand drugs: 547 claims; generic drugs: 8,516 claims; opioid claims: 4,218.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Takia M Oglesby $2,993 ($2,993 in general payments such as food, travel and fees) from 8 companies. The largest payer was Boston Scientific Corporation with $2,315.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.